VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,190 | -66.0% | 23,257 | -63.0% | 0.00% | -75.0% |
| Q4 2022 | $1,592,632 | +29.4% | 62,925 | -1.5% | 0.01% | +33.3% |
| Q3 2022 | $1,231,000 | +212.4% | 63,874 | +313.2% | 0.01% | +200.0% |
| Q2 2022 | $394,000 | -61.9% | 15,460 | -61.5% | 0.00% | -50.0% |
| Q1 2022 | $1,033,000 | +39.0% | 40,149 | +126.2% | 0.00% | +33.3% |
| Q4 2021 | $743,000 | +52.9% | 17,752 | +58.9% | 0.00% | +50.0% |
| Q3 2021 | $486,000 | -8.0% | 11,171 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $528,000 | -12.4% | 11,161 | -5.1% | 0.00% | -33.3% |
| Q1 2021 | $603,000 | -10.4% | 11,761 | -53.2% | 0.00% | 0.0% |
| Q4 2020 | $673,000 | +49.9% | 25,114 | +92.0% | 0.00% | +50.0% |
| Q3 2020 | $449,000 | – | 13,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |